We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
651
CALL
DELISTED
Apellis Pharmaceuticals
APLS
– –
-15,100
Closed -$24K
APLS
652
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-4,200
Closed -$62K
AQST icon
653
Aquestive Therapeutics
AQST
$553M
– –
-124,590
Closed -$80K
ASLE icon
654
AerSale
ASLE
$273M
– –
-178,803
Closed -$2.6M
BEPC icon
655
Brookfield Renewable
BEPC
$6.46B
– –
-11,728
Closed -$418K
BIIB icon
656
CALL
Biogen
BIIB
$30.1B
– –
-7,500
Closed -$16K
BKLN icon
657
Invesco Senior Loan ETF
BKLN
$6.75B
– –
-465
Closed -$9K
BKLN icon
658
PUT
Invesco Senior Loan ETF
BKLN
$6.75B
– –
-100,000
Closed -$33K
BMY icon
659
PUT
Bristol-Myers Squibb
BMY
$130B
– –
-17,500
Closed -$11K
BROS icon
660
Dutch Bros
BROS
$8.66B
– –
-90,000
Closed -$2.85M
BTMD icon
661
Biote Corp
BTMD
$46.7M
– –
-12,970
Closed -$49K
C icon
662
CALL
Citigroup
C
$228B
– –
-67,400
Closed -$11K
C icon
663
PUT
Citigroup
C
$228B
– –
-65,100
Closed -$1.13M
CCJ icon
664
CALL
Cameco
CCJ
$43B
– –
-213,100
Closed -$262K
CCJ icon
665
PUT
Cameco
CCJ
$43B
– –
-20,500
Closed -$105K
CHPT icon
666
CALL
ChargePoint
CHPT
$162M
– –
-27,045
Closed -$240K
CHPT icon
667
ChargePoint
CHPT
$162M
– –
-6,195
Closed -$1.7M
CHPT icon
668
PUT
ChargePoint
CHPT
$162M
– –
-8,060
Closed -$202K
CLM icon
669
Cornerstone Strategic Value Fund
CLM
$2.25B
– –
-54,689
Closed -$462K
CRM icon
670
CALL
Salesforce
CRM
$162B
– –
-7,500
Closed -$3K
CRM icon
671
PUT
Salesforce
CRM
$162B
– –
-8,000
Closed -$63K
CTLP
672
PUT
DELISTED
Cantaloupe
CTLP
– –
-1,100,000
Closed -$802K
CWH icon
673
Camping World
CWH
$655M
– –
-10,000
Closed -$216K
CYH icon
674
CALL
Community Health Systems
CYH
$400M
– –
-50,000
Closed -$3K
DIA icon
675
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
– –
-1,750
Closed -$539K
25 26
27
28 29

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.